Osteonecrosis of the jaw after dental implant placement. A case report


Submitted: 13 June 2017
Accepted: 13 June 2017
Published: 30 March 2014
Abstract Views: 488
PDF: 839
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • J.L. Calvo-Guirado Senior Lecturer of General Dentistry and Implantology, DDS, MS, PhD. Faculty of Medicine and Dentistry, University of Murcia, Murcia, Spain.
  • A. Boquete-Castro Postgraduate Student, Master in Integrated Dentistry and Implantology, DDS, Faculty of Medicine and Dentistry, University of Murcia, Murcia, Spain.
  • J. Guardia Collaborator of Pharmacological Interactions in Dentistry, DDS, PhD. Faculty of Dentistry, University of Granada, Ganada, Spain.
  • A. Aguilar Salvatierra Raya Collaborator of Pharmacological Interactions in Dentistry, DDS, PhD. Faculty of Dentistry, University of Granada, Ganada, Spain.
  • J.M. Martínez González Senior Lecturer of Oral Surgery, DDS, MS, PhD. University Complutense of Madrid, Madrid, Spain.
  • G. Gómez-Moreno Full Professor of Pharmacological Interactions in Dentistry, DDS, PhD. Faculty of Dentistry, University of Granada, Granada, Spain.
Background In the past few years, the occurrence of an oral lesion, called osteonecrosis of the jaw, has increasingly been reported in patients undergoing treatment with systemic bisphosphonates (BPs); however, few papers dealing with oral biphosphonates related osteonecrosis of the jaws (BRONJ) can be found in the literature. The purpose of the present case was to report an occurrence of BRONJ after implant insertion. Case report Ten years ago, eight dental implants were inserted in the jaw of a 65-year-old female. After 5 years of treatment with alendronic acid, a breakdown of the oral mucosa covering the implants occurred with a purulent discharge in the left side of the jaw; periapical radiolucency was present around both distal implants. An en-block resection of the alveolar bone including the two implants was performed. Thirthy-five hyperbaric sessions were taken and no signs of recurrence of the lesion were observed after a follow-up of 20 months. Before the new implant insertion, the patient had suspended the treatment with alendronic acid for 6 months. At the interface of one of the implants, a gap was observed between bone and implant. This bone was non vital, and many osteocyte lacunae were empty. Moreover, this bone appeared to be partially demineralized. Conclusion There is certainly a temporal association between oral BPs use and development of BRONJ, but a correlation does not necessarily mean causation. In patients undergoing oral treatment, clinicians must be aware of the increased risk of implant failure.

Supporting Agencies


Calvo-Guirado, J., Boquete-Castro, A., Guardia, J., Salvatierra Raya, A. A., Martínez González, J., & Gómez-Moreno, G. (2014). Osteonecrosis of the jaw after dental implant placement. A case report. Journal of Osseointegration, 6(1), 15–18. https://doi.org/10.23805/jo.2014.06.01.03

Downloads

Download data is not yet available.

Citations